Tag: Phase I Trial
Aquestive Charts Ambitious Path Forward for Sublingual Emergency Epinephrine
Company updates the public on status of their candidate drug administered under the tongue.
Emergency Epinephrine Film Begins Phase 1 Clinical Trials
First healthy volunteer dosed in a Phase 1 study of AQST-108 for the treatment of allergic reactions including anaphylaxis.
Aravax Presents Additional Positive Phase I Trial Results for PVX108, a...
Trial results demonstrate excellent PVX108 safety profile in patients with prior anaphylaxis and current asthma.
Phase I Trial for New Peanut Allergy Immunotherapy Results in No...
Research details phase one study of peptide-based immunotherapy, which is designed to remove risks of acute reactions during treatment.
Can Fecal Transplant Cure Peanut Allergy? Phase I Trial Underway
Can transplanting the microbiota of a healthy person to that of an allergic individual prevent allergic reactions?
Phase I Trial of Epinephrine Nasal Spray for Anaphylaxis Begins
Could lead the way to approval of a less anxiety provoking method of epinephrine administration.
Novel Peanut Allergy Vaccine Begins Phase I Clinical Trials
Vaccine uses peptides selected from parts of the peanut protein that do not cause life-threatening anaphylactic reactions.
Viaskin Milk Patch Receives Positive Recommendation to Proceed to Phase II
The board overseeing the Phase I study of the milk allergy therapy found no safety concerns.
